Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
743.48
763.75
829.51
817.70
648.68
419.96
381.31
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
743.48
763.75
829.51
817.70
648.68
419.96
381.31
Raw Material Cost
291.83
314.07
365.42
320.96
285.22
198.25
184.82
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
141.09
135.66
122.81
106.52
89.80
74.43
72.51
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.85
2.35
0.95
0.85
0.91
1.07
0.93
Selling and Distribution Expenses
232.83
236.25
213.93
213.84
148.57
113.90
120.30
Other Expenses
-10.61
-11.23
-9.88
-8.35
-6.33
-5.17
-4.41
Total Expenditure (Excl Depreciation)
562.46
576.07
604.27
558.66
461.24
335.95
334.43
Operating Profit (PBDIT) excl Other Income
181
187.7
225.2
259
187.39999999999998
84
46.900000000000006
Other Income
13.00
1.48
1.98
4.89
2.38
1.20
1.15
Operating Profit (PBDIT)
216.52
208.20
245.78
281.50
205.48
98.40
61.40
Interest
2.85
2.35
0.95
0.85
0.91
1.07
0.93
Exceptional Items
-0.10
0.00
0.03
-0.01
-0.77
-5.13
-0.18
Gross Profit (PBDT)
451.65
449.68
464.09
496.74
363.46
221.72
196.49
Depreciation
30.37
28.02
24.33
22.87
21.36
19.59
18.22
Profit Before Tax
183.20
177.83
220.53
257.77
182.45
72.61
42.08
Tax
42.90
40.81
50.11
58.30
29.55
11.52
2.61
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
140.44
136.88
170.34
199.67
153.08
61.06
39.27
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
140.44
136.88
170.34
199.67
153.08
61.06
39.27
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.08
-0.01
-0.04
-0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
140.36
136.88
170.30
199.66
153.08
61.06
39.27
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.06
0.06
0.06
0.06
0.06
0.06
0.06
Reserves
664.41
572.03
539.39
520.01
470.98
373.70
322.39
Earnings per share (EPS)
2.75
2.68
3.29
3.73
2.76
1.1
0.71
Diluted Earnings per share
2.75
2.68
3.29
3.73
2.76
1.1
0.71
Operating Profit Margin (Excl OI)
23.29%
23.4%
26.46%
31.03%
28.02%
18.48%
11.02%
Gross Profit Margin
28.73%
26.95%
29.52%
34.32%
31.42%
21.96%
15.81%
PAT Margin
18.89%
17.92%
20.53%
24.42%
23.6%
14.54%
10.3%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -2.65% vs -7.93% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 2.56% vs -19.61% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -1.55% vs -15.22% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 16.67% vs 166.67% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Laboratorios Farmaceúticos Rovi SA With
Figures in Million
Consolidate Annual Results
Change(EUR)
Change(%)
Net Sales
743.48
7,524.00
-6,780.52
-90.12%
Other Operating Income
0.00
0.00
0.00
Total Operating income
743.48
7,524.00
-6,780.52
-90.12%
Raw Material Cost
291.83
4,838.00
-4,546.17
-93.97%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
141.09
2,170.00
-2,028.91
-93.50%
Power Cost
0
0
0.00
Manufacturing Expenses
2.85
625.00
-622.15
-99.54%
Selling and Distribution Expenses
232.83
1,063.00
-830.17
-78.10%
Other Expenses
-10.61
-242.20
231.59
95.62%
Total Expenditure (Excl Depreciation)
562.46
6,274.00
-5,711.54
-91.04%
Operating Profit (PBDIT) excl Other Income
181.02
1,250.00
-1,068.98
-85.52%
Other Income
13.00
-18.00
31.00
172.22%
Operating Profit (PBDIT)
216.52
1,668.00
-1,451.48
-87.02%
Interest
2.85
625.00
-622.15
-99.54%
Exceptional Items
-0.10
30.00
-30.10
-100.33%
Gross Profit (PBDT)
451.65
2,686.00
-2,234.35
-83.19%
Depreciation
30.37
450.00
-419.63
-93.25%
Profit Before Tax
183.20
623.00
-439.80
-70.59%
Tax
42.90
115.00
-72.10
-62.70%
Provisions and contingencies
0
0
0.00
Profit After Tax
140.44
402.00
-261.56
-65.06%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
140.44
402.00
-261.56
-65.06%
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.08
98.00
-98.08
-100.08%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
140.36
500.00
-359.64
-71.93%
Equity Capital
0
0
0.00
Face Value
0.06
0.25
0.00
Reserves
664.41
5,271.00
-4,606.59
-87.39%
Earnings per share (EPS)
2.75
0.59
2.16
366.10%
Diluted Earnings per share
2.75
0.59
2.16
366.10%
Operating Profit Margin (Excl OI)
23.29%
16.43%
0.00
6.86%
Gross Profit Margin
28.73%
14.26%
0.00
14.47%
PAT Margin
18.89%
5.34%
0.00
13.55%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 74.35 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -2.65% vs -7.93% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 14.04 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 2.56% vs -19.61% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.35 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -1.55% vs -15.22% in Dec 2024
Annual - Interest
Interest 0.28 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 16.67% vs 166.67% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.29%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
